JPRN-UMIN000020392招募中未知
Anti-fibrotic treatment in patients with idiopathic pulmonary fibrosis:A cohort study - Anti-fibrotic treatment in patients with IPF:A cohort study
niversity of Occupational and Environmental Health, Japan0 个研究点目标入组 100 人开始时间: 2015年12月29日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •without patients' consent
研究者
相似试验
招募中
不适用
Idiopathic Pulmonary Fibrosis treated with Anti-fibrotic Drugs Prospective Observational TrialIdiopathic pulmonary fibrosisJPRN-UMIN000019826HO Kinki-Chuo Chest Medical Center100
进行中（未招募）
不适用
A protocol based treatment for debilitating fibrosing skin disorders with (anti-CD-20), rituximabFibrosing skin disordersEUCTR2009-012034-70-BEniversity Hospital Ghent
已完成
4 期
The effect of fibrate therapy in two patients with neutral lipid storage disease with myopathy (NLSDM).NL-OMON37985niversiteit Maastricht10
进行中（未招募）
不适用
The effect of lipid lowering medication on lipid accumulation in patients with neutral lipid storage disease with muscle weakness.eutral lipid storage disease with myopathyMedDRA version: 13.1Level: PTClassification code 10007636Term: CardiomyopathySystem Organ Class: 10007541 - Cardiac disordersMedDRA version: 13.1Level: HLGTClassification code 10013317Term: Lipid metabolism disordersSystem Organ Class: 10027433 - Metabolism and nutrition disordersMedDRA version: 13.1Level: PTClassification code 10028641Term: MyopathySystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersEUCTR2011-001205-27-NL
已完成
3 期
Immunoglobulin therapy for patients with idiopathic cardiomyopathy and endomyocardial parvovirus B19 persistence - a prospective, double-blind, randomized, placebo-controlled clinical trialviral mediated heartfailure1002859310047438NL-OMON33416Sanquin Plasmaproducten50